Hypertension
RSSArticles
-
New cardiac guidelines will impact your care: How will your practice change?
-
Clinical Briefs: Spironolactone for refractory hypertension; amoxicillin for purulent rhinorrhea; exercise testing in elderly men
-
Clinical Briefs in Primary Care Supplement
-
PCI Outcomes in Women vs Men
Percutaneous coronary intervention (PCI) is performed in more than 600,000 patients annually in the United States, and women make up approximately one-third of this population. -
Current Drug Usage in Atrial Fibrillation
This paper reviews drug therapy in patients with atrial fibrillation in the Medicare population. The author extracted a 5% sample of Medicare beneficiaries who were enrolled in Medicare Part D. -
Clinical Briefs in Primary Care Supplement
-
Risk of Bleeding with Warfarin Therapy for Atrial Fibrillation
This paper details the result of a population-based cohort study of all Ontario, Canada, residents older than 66 years of age who began warfarin therapy for atrial fibrillation over an 11-year period. -
Risk of Angioedema with Drug Therapy
Angioedema is an infrequent, but serious, adverse event from drug therapy. Drugs that affect the renin-angiotensin-aldosterone system have been linked to angioedema, but the relative frequency of this complication with these drugs is poorly understood. -
CABG Better in Elderly, PCI Better in Young?
As our population ages and outcomes from revascularization also improve, more elderly patients are being referred for coronary artery bypass graft surgery (CABG) and for percutaneous coronary intervention (PCI). -
Pharmacology Watch: Zolpidem and Risk of Falls in Hospitalized Patients
Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions.